Content
The content of medical knowledge in this section of the site of the Lactology Foundation is intended for the practical needs of doctors, pharmacists and students in these specialties. It is more than reasonable to consult other authoritative medical sources before using our medical knowledge.
- Pulmonology
- Cardiology
- Nephrology
- Emergency medicine
- Gastroenterology
- Hematology
- Oncology
- Rheumagology
- Allergology
- Neurology and Neurosurgery
- Endocrinology
- Pharmacotherapy and other medical knowledge
Retroperitoneal Pain
Pain that originates from the
retroperitoneal region generally
radiates to the back, the lumbar
region on both sides of the spinal
column, and, more rarely, to the
flanks and ventrally.
Spinal
diseases must be excluded first.
Classification. Retroperitoneal pain can be
classified as
follows:
➤ acute or chronic
➤ caused by benign or malignant diseases
➤
caused by renal or non-renal diseases.
The
transitions are smooth, particularly because
ureteral blockage is a very common cause of
retroperitoneal pain, and can generally be
diagnosed by sonography, intravenous urography,
CT or MRI.
Causes. Important causes are:
➤
nephrolithiasis or urolithiasis with typical
ureteral colic
➤ papillary necrosis
➤
hydronephrosis of various etiologies.
Retroperitoneal Fibrosis
The clinical
picture of retroperitoneal fibrosis can be
associated with severe lower back pain.
It
can be classified into:
➤ the idiopathic
form: Ormond disease
➤ symptomatic
retroperitoneal fibrosis: Ormond-like
alterations resulting from:
− inflammatory
processes (e.g., pancreatitis, distal ileitis,
diverticulitis, tuberculous spondylitis,
appendicitis, inflammatory aortic aneurysm)
−
tumors (malignant lymphomas, lymph node
metastases [e.g., testicular tumors,
consequences of radiation therapy])
− certain
drugs (e. g., methysergide).
The fibrosis may
result in unilateral or bilateral ureteral
obstruction with the corresponding consequences.
Differential Diagnosis
If there is no
ureteral obstruction, the following causes of
retroperitoneal pain must be considered:
➤
acute appendicitis of retroperitoneal appendix
➤ psoas abscess
➤ renal infarction
➤
retroperitoneal hematoma (e.g., in patients
receiving
anticoagulants)
➤ Wilms tumors
(in children)
➤ aortic dissection
➤
vertebrogenic causes (disk disease,
spondylitis).
Please see also our Toxilact data base which is in the following language versions:
Toxilact Deutsche Sprachversion
Toxilact Nederlandstalige versie
Toxilakt έκδοση στην ελληνική γλώσσα
Toxilact English language version
Toxilact magyar nyelvű változat
Toxilact versione in lingua italiana
Toxilact polska wersja językowa
Detailed medical information on more common causes of acute abdomen
Intestinal Pain
Acute Appendicitis
Peritoneal Pain
Pain from Vascular Causes
Retroperitoneal Pain
Abdominal Pain from Intoxication
Toxicological risk during lactation
Toxicological lactation category I - the drug and/or its metabolites are either not eliminated through breast milk or are not toxic to the newborn and cannot lead to the development of absolutely any toxic reactions and adverse consequences for his health in the near and long term. Breast-feeding does not need to be discontinued while taking a given drug that falls into this toxicological lactation category.
Toxicological lactation category II - the drug and its metabolites are also eliminated through breast milk, but the plasma:milk ratio is very low and/or the excreted amounts cannot generate toxic reactions in the newborn due to various reasons, including degradation of the drug in the acid pool of the stomach of the newborn. Breastfeeding does not need to be discontinued while taking this medicine.
Toxicological lactation category III - the drug and/or its metabolites generate in breast milk equal to plasma concentrations or higher, and therefore the possible development of toxic reactions in the newborn can be expected. Breastfeeding should be discontinued for the period corresponding to the complete elimination of the drug or its metabolites from the mother's plasma.
Toxicological lactation category IV - the drug and/or its metabolites generate a plasma:milk ratio of 1:1 or higher and/or have a highly toxic profile for both the mother and the newborn, therefore their administration is incompatible with breastfeeding and it should to stop completely, and not just for the period of taking the drug, or to look for a less toxic therapeutic alternative.